... Area biotech company's potentially functional cure for the disease. ... February has delayed Vir Biotechnology Inc. (NASDAQ: VIR) from pulling ...
News
- How Ukraine war hit a Vir Biotechnology trial targeting hepatitis - San Francisco Business Times
- Bio-Rad: Q1 Earnings Snapshot - San Antonio Express-News
The maker of instruments used in biomedical research posted revenue of $700.1 million in the period. Bio-Rad shares have decreased 30% since the ...
- Seattle Genetics: Q1 Earnings Snapshot - MySA
The biotechnology company posted revenue of $426.5 million in the period ... These are San Antonio's hottest neighborhoods right now, according to ...
- Seattle Genetics: Q1 Earnings Snapshot - San Antonio Express-News
The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share. The biotechnology company posted ...
- Bio-Rad: Q1 Earnings Snapshot - MySA
The maker of instruments used in biomedical research posted revenue of $700.1 ... Historic Hemisfair home in downtown San Antonio up for lease.